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Shelterin, a six-member complex, protects telo-
meres from nucleolytic attack and regulates their
elongation by telomerase. Here, we have developed
a strategy, called MICro-MS (Mapping Interfaces
via Crosslinking-Mass Spectrometry), that combines
crosslinking-mass spectrometry and phylogenetic
analysis to identify contact sites within the complex.
This strategy allowed identification of separation-of-
function mutants of fission yeast Ccq1, Poz1, and
Pot1 that selectively disrupt their respective interac-
tions with Tpz1. The various telomere dysregulation
phenotypes observed in these mutants further em-
phasize the critical regulatory roles of Tpz1-cen-
tered shelterin interactions in telomere homeostasis.
Furthermore, the conservation between fission yeast
Tpz1-Pot1 and human TPP1-POT1 interactions led
us to map a human melanoma-associated POT1
mutation (A532P) to the TPP1-POT1 interface. Dimin-
ished TPP1-POT1 interaction caused by hPOT1-
A532P may enable unregulated telomere extension,
which, in turn, helps cancer cells to achieve re-
plicative immortality. Therefore, our study reveals
a connection between shelterin connectivity and
tumorigenicity.INTRODUCTION
The six-member telomere shelterin complex is vital for eukary-
otic cells. It functions to regulate telomere elongation by telome-
rase, as well as to protect the ends of linear chromosomes from
degradation and recognition as DNA damage sites (Artandi and
Cooper, 2009; Jain and Cooper, 2010; Palm and de Lange,
2008). In human cells, the shelterin complex consists of
double-stranded DNA (dsDNA) binders TRF1 and TRF2, single-
stranded DNA (ssDNA) binder POT1, as well as RAP1, TIN2,
and TPP1 (de Lange, 2005). The shelterin connects telomericCell RepdsDNA with ssDNA by forming a proteinaceous bridge via pro-
tein interactions within the shelterin. Specifically, telomeric
dsDNA binders TRF1 and TRF2 recruit TIN2 and RAP1 to the
telomere; TIN2 then recruits TPP1-POT1 complex to the telo-
mere (Takai et al., 2011). Since POT1 directly binds to the telo-
meric ssDNA, where telomere elongation by telomerase hap-
pens, TRF1-initiated POT1 loading to the telomere 30 end via
shelterin interactions is believed to directly block telomerase
from elongating telomeres (Loayza and De Lange, 2003). Shel-
terin architecture in fission yeast, Schizosaccharomyces pombe,
closely resembles that of mammals (Miyoshi et al., 2008) (Fig-
ure 1A). Either its dsDNA binder Taz1 (homolog of hTRF1/2)
(Cooper et al., 1997) or its ssDNA binder Pot1 (Baumann and
Cech, 2001) can independently recruit other shelterin compo-
nents, Rap1, Poz1 (hTIN2 homolog), and Ccq1, to telomeres
(Miyoshi et al., 2008). Using S. pombe as a model system, we
recently discovered that the complete linkagewithin the shelterin
complex, rather than individual shelterin components per se,
regulates the extendibility of telomeres by telomerase (Jun
et al., 2013). Disruption of this linkage leads to unregulated telo-
mere elongation. These previous studies emphasized a critical
role of shelterin complex assembly in telomere length regulation.
Indeed, several human POT1 variants were found to predispose
to the development of familial melanoma and carriers of some of
these mutations have elongated telomeres (Robles-Espinoza
et al., 2014; Shi et al., 2014). These mutations may allow cancer
cells to achieve replicative immortality, and thus provide the
same outcome as previously identified TERT (telomerase re-
verse transcriptase) promoter mutations (Horn et al., 2013;
Huang et al., 2013) that lead to cancer-specific TERT activation
(Borah et al., 2015). Most of melanoma-associated POT1 muta-
tions reside in the highly conserved oligonucleotide and oligo-
saccharide-binding (OB) domains of POT1, thereby disrupting
POT1-telomeric ssDNA interaction (Robles-Espinoza et al.,
2014; Shi et al., 2014). In addition, one mutation, Ala532Pro
(A532P), was found in the C terminus of POT1, which con-
tains the TPP1-binding domain (Shi et al., 2014). However, the
mechanism by which POT1-A532P facilitates melanoma forma-
tion is still unknown. To understand the role of shelterin com-
plex in regulating telomere states, we need to have accurate
information about protein-protein interfaces between shelterinorts 12, 2169–2180, September 29, 2015 ª2015 The Authors 2169
Figure 1. Fission Yeast Shelterin Complex and a Strategy—MICro-
MS—to Dissect Its Interaction Interfaces
(A) Fission yeast shelterin complex is composed of telomeric sequence-spe-
cific double-stranded and single-stranded DNA binding proteins, Taz1 and
Pot1, respectively, accompanied by their protein interaction partners, Rap1,
Poz1, and Tpz1, forming a bridge between Taz1 and Pot1. If the deletion of a
telomere protein causes telomere elongation, this protein is regarded as a
negative regulator of telomere lengthening, and is therefore labeled ‘‘’’,
otherwise, labeled ‘‘+’’. For clarity, the stoichiometry of each individual
component is not indicated in the figure and therefore only one copy of each
component is shown.
(B) Schematic illustration of MICro-MS strategy to identify contact residues at
the interfaces of protein interactions. The MS-cleavable crosslinker DSSO
chemically crosslinks neighboring lysine (K) residue pairs of two interacting
proteins, which, in turn, can be identified via sequencing protease-digested
crosslinked peptide pairs by multistage tandem mass spectrometry. The
identified crosslinked residues are then mapped to the phylogenetically
compiled sequence alignment. Around the locations of the crosslinked resi-
dues, mutations are individually introduced to the conserved residues. In vitro
GST pull-down and/or in vivo co-immunoprecipitation assays are subse-
quently performed to evaluate the degree that introduced mutations disrupt
the targeted protein-protein interaction.components, and therefore a complete dissection of the in-
dividual interactions. However, obtaining structural information
regarding this complex by X-ray crystallography or nuclear
magnetic resonance (NMR) has proved challenging. Alternative
approaches are needed to enable us to acquire protein inter-
faces information without the requirement for high-resolution
structures.2170 Cell Reports 12, 2169–2180, September 29, 2015 ª2015 The AIn recent years, crosslinking mass spectrometry (XL-MS) has
becomean increasingly valuable tool for studying protein-protein
interactions and structural interrogation of protein complexes
due to technological advancement in mass spectrometry (MS)
instrumentation, new development of crosslinking reagents and
bioinformatics tools to facilitate MS analysis of crosslinked pep-
tides (Erzberger et al., 2014; Kaake et al., 2014; Kao et al., 2011,
2012; Politis et al., 2014; Walzthoeni et al., 2013; Yang et al.,
2012), and an innovative algorithm developed for integrative
structural biology utilizing distance restraints obtained from
inter-subunit chemical crosslinking (Vela´zquez-Muriel et al.,
2012). XL-MS studies involve protein crosslinking through a
chemical linker simultaneously reacting with two amino acids
that are in proximity to each other. Digestion of the crosslinked
protein complex followed by peptide sequencing leads to the
identification of crosslinked peptides, and consequently, prox-
imal residue pairs. Because these crosslinked residues are con-
strained by the length of the linker used, the distribution of the
crosslinked residue pairs helps probe protein-protein proximity.
Unlike X-ray crystallography or NMR, XL-MS does not require
sampleswith high concentration andpurity. It also captures inter-
actions fromdynamic states, thusmaking it applicable to a broad
range of protein complexes. However, XL-MS has proved chal-
lenging due to the complex fragmentation pattern of crosslinked
peptides, which frequently prevents unambiguous identifica-
tion of the crosslinked sequences. Recently, a new class of
MS-cleavable crosslinker, disuccinimidyl sulfoxide (DSSO) was
developed, which contains two symmetric MS-cleavable sites
that preferentially cleave prior to the breakage of peptide back-
bones during collision-induced dissociation (CID) (Kao et al.,
2011). In combination with multistage mass spectrometry
(MSn) and tailored bioinformatics tools, DSSO-based XL-MS
workflow enables easy interpretation and unambiguous identifi-
cation of crosslinked peptides and has proved effective in
elucidating structures of protein complexes (Kao et al., 2011,
2012).
In this study, we have developed a strategy MICro-MS (Map-
ping Interfaces via Crosslinking-Mass Spectrometry) by com-
bining DSSO-based XL-MS workflow, phylogenetic sequence
analysis, and in vitro binding assays to identify protein-interac-
tion interfaces without the need of obtaining high-resolution 3D
structure of the complex.With this strategy, we comprehensively
probed protein-protein proximity in Tpz1-centered complex in
fission yeast shelterin and identified separation-of-function mu-
tants of Ccq1, Poz1, or Pot1 that selectively disrupt their respec-
tive interactions with Tpz1. The identified mutants further reveal
the critical regulatory roles of Tpz1 in telomere maintenance. We
also found that POT1-A532P, a melanoma-associated POT1
mutation (Shi et al., 2014), lies in the POT1-TPP1 interface and
causes weakened TPP1-POT1 interaction. Just as disrupting
POT1-telomeric ssDNA interaction in other POT1 mutants pre-
disposed to melanoma, such as Y89C, Q94E, R273L, and
S270N (Robles-Espinoza et al., 2014; Shi et al., 2014), defective
TPP1-POT1 interaction by hPOT1-A532P mutation equivalently
breaks the complete shelterin linkage between telomeric dsDNA
and ssDNA. Therefore, our work links shelterin connectivity to
tumorigenesis. In addition, ourMICro-MS strategy of identifying
separation-of-function mutants to dissect protein complexes foruthors
functional examinations will be generally applicable to other
important multi-component protein complexes in the cell.
RESULTS
Identifying Contact Residues in Protein-Protein
Interaction Interfaces by MICro-MS
We set out to utilize chemical crosslinking coupled with mass
spectrometry (XL-MS) to identify contact residues located in
the interfaces of interacting telomere shelterin components.
Since mutations of the contact residues can selectively disrupt
defined interactions within shelterin components, this strategy
will allow us to identify separation-of-function mutants of shel-
terin components. Separation-of-function mutants can selec-
tively block specific interactions without disrupting overall
protein complex architecture. Thus, they should poise us to
elucidate the roles of specific shelterin interactions in telomere
maintenance without perturbing their roles in chromosome end
protection.
The general workflow is depicted in Figure 1B, in which DSSO
crosslinking of purified protein complexes was first carried out to
covalently connect residues within certain three-dimensional
distance in the protein pairs that are specifically reactive to the
crosslinker. Although the crosslinked residues in the protein
complex might not be directly involved in mediating protein-pro-
tein interactions, they should at least be close to each other sur-
rounding the interface. Therefore, the locations of the cross-
linked residues point out where the binding interface is likely
to be. The optimal crosslinking conditions were used to yield
sufficient amounts of crosslinked products as evaluated by
SDS-PAGE. The resulting crosslinked protein complexes were
digested either in-solution or in-gel with trypsin and/or chymo-
trypsin to obtain the maximum coverage of detectable cross-
linked peptides for LC-MSn analysis. The mass to charge ratios
of DSSO-crosslinked peptides were first measured during MS1
analysis, and they were then subjected to collision induced
dissociation (CID) during MS2. Due to the presence of the robust
sulfoxide C-S cleavage sites in the linker region, MS2 analysis of
a DSSO inter-linked peptide would lead to physical separation of
the two crosslinked peptide constituents, thus allowing for MS3
sequencing of single peptide chains and subsequent identifica-
tion using conventional database searching tools (Kao et al.,
2011). Integration of the MSn data (i.e., MS1, MS2, and MS3) re-
sults in simplified and unambiguous identification of DSSO-
crosslinked peptides (Kao et al., 2011).
After identifying the crosslinked peptides and localizing lysine
residues conjugated by DSSO, wemapped these residues to the
phylogenetically compiled sequence alignment. We reasoned
that functionally important residues (such as those for enzymatic
activity, structural-fold determination, and protein complex as-
sembly) should be evolutionarily conserved, and therefore re-
present leading candidates that contribute to protein-protein
interactions. We introduced mutations to the conserved resi-
dues, especially the hydrophobic residues among them (as
they constitute the hydrophobic core of protein-protein interac-
tions), within approximately 8 to 15 amino acids from the cross-
linked lysines, particularly in the regions where multiple lysine
residues were identified as crosslinking points. In vitro GSTCell Reppull-down and in vivo co-immunoprecipitation assays were sub-
sequently performed to evaluate the degree that the introduced
mutations can disrupt the targeted protein-protein interaction.
Mutations of the contact residues in the protein-protein interac-
tion interface should efficiently disrupt the protein interaction.
We termed this integrated strategy to identify separation-of-
function mutants disrupting specific protein interaction inter-
faces MICro-MS—Mapping Interfaces via Crosslinking-Mass
Spectrometry.
Benchmarking MICro-MS with 3D Structure of
Proteasome Subunits Rpn8-Rpn11 Complex
Next, we assessed the applicability of MICro-MS to a protein
complex with determined high-resolution 3D structure. In
2012, DSSO-based XL-MS strategy was employed to unravel
the structural topology of Saccharomyces cerevisiae 19S pro-
teasome regulatory particle (Kao et al., 2012). Five inter-sub-
unit, DSSO-mediated crosslinks were identified between
Rpn8 and Rpn11 subunits, suggesting their spatial proximity
as well as potential direct protein interaction interfaces be-
tween Rpn8 and Rpn11. In 2014, two groups independently
solved the crystal structure of heterodimer of the MPN
(Mpr1–Pad1–N-terminal) domains of Rpn8 (1–179) and Rpn11
(2–239) (Pathare et al., 2014; Worden et al., 2014). These two
subunits primarily interact with each other through a helices
forming two distinct interfaces. Interestingly, two pairs of
DSSO-crosslinked lysines, Rpn8-K7:Rpn11-K218 and Rpn8-
K28:Rpn11-K96, appear to be close to interface A and interface
B, respectively, as shown in Figures 2A–2C. The rest three
identified lysine-crosslinks locate in the residues beyond the
MPN domains and thus are not covered in the crystal structure.
From the 3D structure, we calculated distances between the
crosslinked lysine pairs to be 19.4 and 18.3 A˚, respectively, fall-
ing in the range of DSSO effective reaction distance (20 A˚). In
Interface A (shown in Figure 2B), the hydrophobic core of the
interface is formed by four-helix bundle between a1, a4 of
Rpn8 and a1, a4 of Rpn11. Specifically, side chains from resi-
dues L15, L16, and L19 in a1 of Rpn8 and residues M212, L216
and L213 in a4 of Rpn11 are the essential constituents of
the hydrophobic interface. Remarkably, these interface resi-
dues are adjacent (within 15 amino acids) in primary sequence
to the crosslinked lysines—K7 in Rpn8 and K218 in Rpn11,
respectively. Moreover, they belong to the most phylogeneti-
cally conserved residues around the crosslinking sites (Figures
S1A and S1B). Interface B (shown in Figure 2C) is located be-
tween a2 of Rpn8 and a2 of Rpn11. A cluster of four methio-
nines: M76 and M79 from Rpn8 as well as M91 and M94
from Rpn11 build the core of the interface, which is flanked
by salt bridges between Rpn8-R24 and Rpn11-T98 and be-
tween Rpn8-D20 and Rpn11-R100. Identified DSSO-cross-
linked lysine pair Rpn8-K28:Rpn11-K96 lies at the edge of the
interface, very close to the interface residues in primary
sequence. Evidently, our benchmarking results demonstrate a
strong correlation between DSSO-crosslinked lysine pairs and
contact residues in protein-interaction interfaces in the primary
sequence. Thus, we are set out to utilize MICro-MS to identify
contact residues in interaction interfaces of protein complexes
with no existing high-resolution 3D structure.orts 12, 2169–2180, September 29, 2015 ª2015 The Authors 2171
Figure 2. Benchmarking MICro-MS Using Rpn8-Rpn11 Complex
(A) Crystal structure of Rpn8-Rpn11 heterodimer is presented with Rpn8
colored in blue and Rpn11 colored in green. The two interfaces are designated
as Interface A and Interface B. The crosslinked lysines boxed in orange are
connected with orange dashed lines; the distances between the lysine pairs
are shown next to the lines.
(B) Close-up view showing a DSSO-crosslinked lysine pair (Rpn8-K7:Rpn11-
K218) and interface A nearby in Rpn8-Rpn11 complex. The hydrophobic
core of the interface is formed by four-helix bundle between a1, a4 of Rpn8
and a1, a4 of Rpn11. Specifically, side chains from residues L15, L16, and
L19 (labeled in blue) in a1 of Rpn8 and residues M212, L216, and L213
(labeled in green) in a4 of Rpn11 are the essential constituents of the hy-
drophobic interface.
(C) Close-up view showing a DSSO-crosslinked lysine pair (Rpn8-K28:Rpn11-
K96) and interface B nearby in Rpn8-Rpn11 complex. Interface B is located
between a2 of Rpn8 and a2 of Rpn11. A cluster of four methionines: M76 and
M79 from Rpn8 (labeled in blue) as well as M91 and M94 from Rpn11 build the
core of the interface (labeled in green), which is flanked by salt bridges be-
tween Rpn8-R24 and Rpn11-T98 and between Rpn8-D20 and Rpn11-R100.
2172 Cell Reports 12, 2169–2180, September 29, 2015 ª2015 The ADissecting the Ccq1-Tpz1 Interacting Interface via
MICro-MS
Tpz1, the fission yeast homolog of the mammalian shelterin
component TPP1 (Houghtaling et al., 2004; Liu et al., 2004;
Sexton et al., 2014; Wang et al., 2007; Ye et al., 2004), is
a linchpin molecule interacting with three other shelterin com-
ponents—Ccq1, Poz1 via its C-terminal domain (Tpz1-CTD),
andwith Pot1 using its N-terminal domain (Tpz1-NTD) (Figure 1A)
(Miyoshi et al., 2008). Our previous work identified Tpz1 mutants
that selectively disrupt the ability of Tpz1 to interact with each of
its interacting partners and revealed an interesting interplay
among the positive and negative regulators of telomere length
homeostasis (Jun et al., 2013). To achieve a complete dissection
of the protein-protein interactions between Tpz1 and its interact-
ing shelterin components, and therefore to define the boundary
between positive and negative telomere regulators, we decided
to further map the Tpz1-interacting surfaces on Ccq1, Poz1, and
Pot1, respectively.
Ccq1 is more than 700 amino acids long, and it is extremely
labor intensive and tedious to identify its point mutations that
disrupt Ccq1-Tpz1 interaction via mutating every phylogeneti-
cally conserved residue in Ccq1. We set out to gather interface
information by utilizing MICro-MS strategy. As Ccq1 (130–439)
interacts with Tpz1 (415–458), we co-expressed recombinant
Ccq1 (130–439) with Tpz1 (415–458) in E. coli and purified the
complex. We then subjected the complex to chemical crosslink-
ing using an optimized concentration of DSSO—5.0 mM. As
shown in Figure 3A, the crosslinked Ccq1 (130–439) and Tpz1
(415–458) complex was observed, while the free form of both
Ccq1 (130–439) and Tpz1 (415–458) decreased concomitantly.
The covalently crosslinked Ccq1 (130–439)/Tpz1 (415–458)
shows molecular weight of 72 kDa. This agrees with the
Ccq1-Tpz1 complex forming a dimer of Ccq1-Tpz1 heterodimer,
as we observed in gel filtration analysis, in which the protein
complex was examined in its native form (Figure S2A). The
tryptic digests of crosslinked Ccq1-Tpz1 complexes were then
analyzed by LC-MSn. Figure 3B illustrates a representative
MSn analysis for unambiguous identification of DSSO cross-
linked peptides. As shown, MS2 analysis of a selected peptide
(m/z 554.03334+) yielded two peptide fragment pairs, i.e., aA/bT
(m/z 420.752+/678.312+) and aT/bA (m/z 432.20
2+/662.832+),
which is characteristic to a hetero-inter-linked peptide (a-b)
(Kao et al., 2011). Each fragment (aA, bT, aT, or bA) represents
one of the two crosslinked peptide constituents modified with
the defined remnants of the linker after its cleavage, thus sug-
gesting this peptide is a DSSO inter-linked peptide. The domi-
nant fragment pair ions (aA/bT) were subsequently subjected to
MS3 analysis, in which the series of b (b2b5) and y (y1y5)
ions detected for the aA fragment unambiguously identified it
as 171IQEKAIR
176 of Ccq1, while the series of b (b2b7, b9) and
y (y2y3, y5, y7y9) ions detected for bT unambiguously identified
the peptide as 434KTPIPDYDFM(Ox)K
443 of Tpz1. Finally, integra-
tion of the MSn data precisely identifies the inter-link betweenIdentified DSSO-crosslinked lysine pair Rpn8-K28:Rpn11-K96 (linked by an
orange dash line) lies at the edge of the interface, very close to the interface
residues in primary sequence.
uthors
Figure 3. Dissecting Ccq1-Tpz1 Interacting
Interface via MICro-MS
(A) SDS-PAGE of Ccq1 (130–439) and Tpz1 (415–
458) complex before and after being crosslinked by
DSSO.
(B) (a) MS2 spectrum of a quadruply charged
crosslinked peptide a-b (m/z 554.28634+), in which
two characteristic peptide fragment pairs were
detected: aA/bT (m/z 420.75
2+/678.312+) and aT/bA
(m/z 432.202+/662.832+). MS3 spectra of (b) aA (m/z
420.752+) and (c) bT (m/z 678.31
2+) fragment ions
detected in (a), which unambiguously identified
their sequences as IQEKAIR of Ccq1 and KT
PIPDYDFMOxK of Tpz1, respectively, demon-
strating a linkage between residue K174 of Ccq1
and K434 of Tpz1. KA, alkene-modified lysine; KT,
unsaturated thiol-modified lysine.
(C) In vitro GST pull-down assays testing the
binding of Ccq1 mutants and Poz1 to GST-Tpz1-
CTD (406–508). GST-Tpz1-CTD-L449A serves as
the negative control. Input: 1/20 of Ccq1 and 1/5
Poz1 before their incubation with GST-Tpz1-CTD.
(D) Co-immunoprecipitation (coIP) assays evalu-
ating the binding between full-length Tpz1 and
Ccq1 mutants. tpz1-L449A serves as the negative
control. Cdc2 was shown as the loading control.
Input: 1/30 of input WCE (whole-cell extract).
(E) Southern blot analysis of EcoRI-digested
genomic DNA using the telomere DNA probe for
the indicated ccq1mutant strains from successive
re-streaks on agar plates. ccq1mutants disrupting
Ccq1-Tpz1 interaction have shorter telomeres. In
the telomere length analysis southern blots pre-
sented in this paper, the 1 kb plus marker from
Life Technologies is used. Wild-type cells are de-
noted as ‘‘WT’’ in the blot. pol1+ indicates the
EcoRI-digested pol1+ DNA fragment as loading
control.Tpz1-K434 and Ccq1-K174, suggesting their close proximity
in three-dimensional space. Based on our previous study,
Tpz1-L449A is able to disrupt Ccq1-Tpz1 interaction both
in vitro and in fission yeast cells. The MSn identification of
Tpz1-K434 and Ccq1-K174 crosslinked by DSSO in the Tpz1-
Ccq1 complex (Figure 3B) is remarkable, because Tpz1-K434
is only 15 amino acids away from the previously confirmed
Ccq1-interacting site on Tpz1 (L449) (Jun et al., 2013). We there-
fore suspected that Ccq1 residues that mediate Ccq1-Tpz1
interaction should also be around K174 of Ccq1, the residue
crosslinked to Tpz1-K434. Next, we introduced point mutations
individually to several conserved residues around the K174 re-
gion of Ccq1 (Figure S2B), and then the purified recombinant
Ccq1 mutants produced in E. coli were subjected to GST pull-
down assays to evaluate their binding ability to GST-Tpz1-
CTD. As shown in Figure 3C, among nine Ccq1 mutants,
Ccq1-L151R and Ccq1-F157A/K174E completely abolished as-
sociation between Ccq1 and Tpz1. In addition, Ccq1-L171R,
Ccq1-K174E, Ccq1-I175R, and Ccq1-F178R all significantly
diminished Ccq1-Tpz1 interaction, whereas Ccq1-V152R and
Ccq1-L177R still retain wild-type binding to Tpz1. Furthermore,
we also confirmed that Ccq1 mutations, which interfere withCell RepCcq1-Tpz1 interaction in vitro, also affect full-length Ccq1-
Tpz1 interaction to the similar degree in co-immunoprecipitation
assays (Figure 3D); however, they still maintain their interactions
with Clr3—the interaction partner of Ccq1 in the SHREC com-
plex (Sugiyama et al., 2007) (Figure S2C). In addition, chromatin
immunoprecipitation (ChIP) analysis of these Ccq1 mutants
indicates that they can localize to telomeres as well (Figure S2D).
Therefore, we identified separation-of-function mutants of Ccq1,
specifically disrupting Ccq1-Tpz1 interaction.
After obtaining Ccq1 mutants disrupting Ccq1-Tpz1 interac-
tion, we further asked whether these Ccq1 mutants eliminate
the function of Ccq1 as a positive regulator of telomere length.
As predicted, telomere length in ccq1-L151R and ccq1-F157A/
K174E pombe cells, in which Ccq1-Tpz1 interaction is com-
pletely abolished, is stable but 150 bp shorter than that in
the wild-type cells, reminiscent of tpz1-L449A cells (Figures
S2E and 3E) (Armstrong et al., 2014; Jun et al., 2013).
S. pombe cells bearing ccq1+ mutations that significantly
diminish Ccq1-Tpz1 interaction, such as ccq1-L171R, ccq1-
I175R, and ccq1-F178R, also have similarly shorter telomeres
as tpz1-L449A cells. However, cells bearing ccq1+ muta-
tions, ccq1-V152R and ccq-L177R, which have little effect onorts 12, 2169–2180, September 29, 2015 ª2015 The Authors 2173
Figure 4. A Poz1 Mutation that Prevents
Tpz1 Binding Results in Dramatic Telomere
Elongation
(A) SDS-PAGE of full-length Poz1 and Tpz1 (406–
508) complex before and after being crosslinked
by DSSO.
(B) (a) MS2 spectrum of a triply charged cross-
linked peptide a-b (m/z 429.56083+) in which two
characteristic peptide fragment pairs were de-
tected: aA/bT (m/z 304.19
2+/662.30+) and aT/bA (m/
z 320.172+/630.33+). MS3 spectra of (b) aA (m/z
304.192+) and (c) bT (m/z 662.30
+) fragment ions
detected in (a), which unambiguously identified
their sequences as DWKAK of Tpz1 and HKTIR of
Poz1, respectively, demonstrating a linkage be-
tween residue K192 of Poz1 and K499 of Tpz1. KA,
alkene-modified lysine; KT, unsaturated thiol-
modified lysine.
(C) In vitro GST pull-down assays testing the
binding of Poz1 mutants to GST-Tpz1-CTD (406–
508). Poz1-R196E (colored in green) is defective
in binding to GST-Tpz1-CTD. GST-Tpz1-CTD-
I501R/R505E serves as the negative control. Input:
1/15 of the samples before their incubation with
GST-Tpz1-CTD.
(D) poz1-R196E disrupts Poz1-Tpz1 interaction as
evaluated by coIP assays. tpz1-I501R serves as
the negative control. Cdc2 was shown as the
loading control. Input: 1/30 of input WCE.
(E) Telomere length analysis southern blots for the
indicated poz1 mutant strains from successive re-
streaks on agar plates. poz1-R196E causes telo-
mere elongation.
(F) Double-mutant strain poz1-R196E/tpz1-I501R
cells have elongated telomeres similar to those of
poz1-R196E or tpz1-I501R cells.Ccq1-Tpz1 interaction, maintain wild-type telomere length.
Furthermore, tpz1-L449A/ccq1-F157A/K174E double-mutant
cells have an almost identical telomere phenotype as either
ccq1-F157A/K174E or tpz1-L449A cells (Figure S2F), indicating
the mutations, either in Tpz1 or in Ccq1, affect the same func-
tionality in telomere maintenance pathway. Much like tpz1-
L449A cells, which maintain their short telomeres via homolo-
gous recombination pathway involving rad51+, ccq1-F157A/
K174E cells also require rad51+ to maintain their telomeres as
deletion of rad51+ in ccq1-F157A/K174E immediately abrogates
the stably maintained short telomeres in ccq1-F157A/K174E
cells (Figure S2G). Taken together, utilizing MICro-MS, we
were able to identify Ccq1 mutants that are defective in interact-
ing with Tpz1, and we found that these Ccq1 mutants are func-
tionally equivalent to tpz1-L449A in telomere maintenance.
A Poz1 Mutation that Prevents Tpz1 Binding Results in
Dramatic Telomere Elongation
Having successfully employed MICro-MS to dissect Ccq1-Tpz1
interaction, we next applied this approach to define the signifi-2174 Cell Reports 12, 2169–2180, September 29, 2015 ª2015 The Authorscance of the Poz1-Tpz1 interaction. Using
the same procedure as described above
for Ccq1-Tpz1 complex, we analyzed
DSSO-crosslinked Poz1-Tpz1 complex(Figure 4A) to identify crosslinked peptides and the lysine pairs
that make the linkages. Interestingly, Tpz1-K499, a residue adja-
cent to Tpz1-I501—a previously identified Poz1-interacting res-
idue in Tpz1 (Jun et al., 2013), was found to crosslink to K180,
K190, and K192 of Poz1 (Figures 4B, S3A, and S3B). In addition,
Tpz1-K500 was also observed to crosslink to Poz1-K190 (Fig-
ure S3C). This result suggests that a region around K180 and
K192 of Poz1 may contain Tpz1 contact sites (Figure S3D). We
therefore introduced mutations individually to three conserved
residues around this region, Poz1-W174R, R196E, and W209A,
and performedGST pull-down assay to evaluate their Tpz1 bind-
ing ability. Among these three Poz1 mutants, only Poz1-R196E
completely abrogated Poz1-Tpz1 interaction as shown in Fig-
ure 4C. Accordingly, we found that Poz1-R196E also caused
loss of Poz1-Tpz1 interaction in the S. pombe cells as detected
by co-immunoprecipitation assays (Figure 4D).
We generated a yeast strain carrying the poz1-R196E muta-
tion to evaluate its importance for telomere length homeostasis.
poz1-R196E mutant cells had dramatically elongated telomeres
(Figures 4E and S3E), consistent with the phenotype previously
Figure 5. Pot1 Is a Negative Regulator of
Telomere Length and Protects Telomeres
Redundantly with Tpz1
(A) SDS-PAGE of full-length Pot1 and Tpz1-NTD
(1–234) complex before and after being cross-
linked by DSSO.
(B) (a) MS2 spectrum of a quadruply charged
crosslinked peptide a-b (m/z 983.51084+) in which
two characteristic peptide fragment pairs were
detected: aA/bT (m/z 749.89
2+/1209.122+) and aT/
bA (m/z 764.88
2+/1193.132+). MS3 spectra of (b) aA
(m/z 748.892+) and (c) bT (m/z 1209.12
2+) fragment
ions detected in (a), which unambiguously identi-
fied their sequences as DIKAANNIQFHWK of
Tpz1 and EYIPVIGNTKTTDHQSLTFLQK of Pot1,
respectively, indicating a linkage between residue
K180 of Tpz1 and K535 of Pot1. KA, alkene-
modified lysine; KT, unsaturated thiol-modified
lysine.
(C) In vitro GST pull-down assays testing the
binding of Pot1 mutants to GST-Tpz1-NTD (2–
234). Pot1-I453R and Pot1-F520A (colored in
orange) abolish the in vitro interaction with GST-
Tpz1-NTD. GST-Tpz1-NTD-I200R serves as the
negative control. Input: 1/15 of the samples before
their incubation with GST-Tpz1-NTD.
(D) CoIP assays evaluating the binding of Pot1
mutants and Ccq1 to full-length Tpz1. pot1-I453R
and pot1-F520A completely disrupt Pot1-Tpz1
interaction. tpz1-I200R serves as the negative
control. Cdc2 was shown as the loading control.
Input: 1/30 of input WCE.
(E) Telomere length analysis southern blots for
the indicated pot1 mutant strains from successive
re-streaks on agar plates. pot1-I453R and pot1-
F520A strains, in which Pot1-Tpz1 interaction is
disrupted, have elongated telomeres.
(F) Telomere deprotection phenotypewas observed
in both pot1-F520A/tpz1-I200R and pot1-I453R/
tpz1-I200R double mutants.observed for tpz1-I501R mutant strain (Jun et al., 2013), which
also fails to form the Poz1-Tpz1 complex. Moreover, when
poz1-R196E was coupled with tpz1-I501R, the double mutant
also showed elongated telomere, similar to poz1-R196E single
mutant with no additional telomere elongation (Figure 4F). These
results indicate that Poz1-R196 is indeed functionally equivalent
to Tpz1-I501 in mediating Tpz1-Poz1 interaction, a key linkage
point in the negative regulation force imposed by shelterin com-
plex upon telomerase.
Pot1 Is a Negative Regulator of Telomere Length and
Protects Telomeres Redundantly with Tpz1
In S. pombe, Pot1 is the direct single-stranded telomeric DNA
binder and is responsible for telomere 30 end protection by form-
ing a complex with Tpz1 (Miyoshi et al., 2008). Deletion of either
protein can result in chromosome circularization, whereas
disruption of Tpz1-Pot1 interaction by the Tpz1-I200R mutation
conversely leads to telomere elongation (Jun et al., 2013). Pot1
interacts with the N-terminal domain of Tpz1 (Tpz1-NTD), which
is distinct from Ccq1 and Poz1 binding regions in the C-terminalCell Repdomain of Tpz1 (Tpz1-CTD). To achieve the complete dissection
of the interfaces in Tpz1-mediated negative regulation of telo-
mere elongation, we aimed to identify regions in Pot1 that
mediate its interaction with Tpz1-NTD. As shown in Figure 5A,
efficient crosslinking by DSSO was achieved with the purified
Pot1–Tpz1-NTD complex. Further MSn analyses revealed that
two lysine residues (K180 and K226) in proximity to I200 position
of Tpz1 were crosslinked to Pot1 (K403, K535, and K553) (Fig-
ures 5B and S4A–S4C). To design separation-of-function muta-
tions in Pot1 for specific disruption of the Pot1-Tpz1 interaction,
several conserved residues around the crosslinked lysines were
mutated (Figure S4D), and themutants were tested for their inter-
actions with Tpz1 both in vitro (by GST pull-down) (Figure 5C)
and in vivo (by co-immunoprecipitation) (Figure 5D). We found
that Pot1-I453R and Pot1-F520A completely disrupt Pot1-Tpz1
binding both in vitro and in vivo. In addition, we examined the
crystal structure of the Oxytricha nova homolog of Pot1-Tpz1
complex—TEBP-a/b (Horvath et al., 1998) and found that sec-
ondary structure prediction of Pot1 imposed onto its homolo-
gous TEBP-a/b structure placed I453 and F520 of Pot1 at theorts 12, 2169–2180, September 29, 2015 ª2015 The Authors 2175
Figure 6. A Human Family Melanoma-Associated POT1 Variant Has
Compromised hPOT1-hTPP1 Interaction
(A) In vitro GST pull-down assays testing the binding of hPOT1 mutants to
GST-hTPP1-NTD (89–334). hPOT1-A532P (boxed in red) was identified in
familiar melanoma patients. hPOT1-V529R and hPOT1-L538R (boxed in red)
also negatively affect the interaction between hPOT1 and GST-hTPP1-NTD.
All hPOT1 (WT and mutants) are labeled with 35S and visualized by Bio-Rad
Phosphorimager. GST-hTPP1-NTD and GST are visualized by Coomassie
blue staining.
(B) Quantification of the binding betweenGST-hTPP1-NTD and hPOT1mutants
from (A). The interaction between GST-hTPP1-NTD and hPOT1-WT is set to 1.protein interaction interface (Figure S4D), consistent with our
binding data. We performed ChIP analyses to evaluate telomeric
localizations of Pot1 and Ccq1 in Pot1-Tpz1 interaction-defec-
tive Pot1 mutant strains (Figures S4E and S4F), demonstrating
that thesemutations only disrupt Pot1-Tpz1 interactionwithmin-
imum effect on Pot1 or Ccq1 telomere association. In agreement
with this, we found that these Pot1mutants can bind to telomeric
ssDNA in gel-shift assays (Figure S4G). Reminiscent of tpz1-
I200R cells, telomeres in both pot1-I453R and pot1-F520A
mutant cells are elongated (Figures 5E and S4H) (Jun et al.,
2013), indicating that Pot1 is also a negative regulator of telo-
mere length. However, when we coupled pot1-I453R or pot1-
F520A with tpz1-I200R, the double mutant showed no telomere
signal, with part of the subtelomeric regions disappeared con-
comitantly (Figures 5F and S4I). These results strongly suggest
that there is an alternative pathway that Tpz1 is involved in, in
addition to the Pot1 pathway, to redundantly protect telomere
erosion.
In summary, we have successfully employed MICro-MS to
comprehensively map Tpz1-centered protein-protein interfaces
in fission yeast shelterin. As a result, we successfully identified
mutants of Ccq1, Poz1, and Pot1 that selectively disrupt their
respective interactions with Tpz1, the linchpin molecule that is
functionally positioned between the positive and negative regu-
lators of telomere elongation.2176 Cell Reports 12, 2169–2180, September 29, 2015 ª2015 The AAHumanPOT1 Variant in FamilyMelanoma Patients Has
Compromised hPOT1-hTPP1 Interaction
Replicative telomere attrition is one of the key restriction mech-
anisms that form a key barrier to infinite cell proliferation. As a
result, a hallmark of cancer cells is their ability to circumvent mul-
tiple regulatory mechanisms that normally restrict cell prolifera-
tion (Hanahan and Weinberg, 2011). The integrity of telomere
shelterin structure is essential for telomere length homeostasis,
which, in turn, enables the anti-proliferative barrier set by short
telomeres (Gu¨nes and Rudolph, 2013). Indeed, it has been
shown that long telomeres can bypass the requirement of telo-
merase activation in the process of tumorigenesis (Taboski
et al., 2012). Recently, two studies have linked 4%–6%of familial
melanoma cases to germline variants in the gene encoding hu-
man POT1, the first shelterin component found to be mutated
in cancer (Robles-Espinoza et al., 2014; Shi et al., 2014). Among
these hPOT1 variants, many alter key residues in the N-terminal
OB domains of POT1, causing the inability of hPOT1 to bind to
telomeric ssDNA and leading to longer telomeres (Robles-Espi-
noza et al., 2014; Shi et al., 2014). However, one familial mela-
noma hPOT1 variant (hPOT1-A532P) contains a point mutation
in the C terminus of hPOT1, and therefore is unlikely to disrupt
POT1-ssDNA binding. Given our knowledge gained from fission
yeast Pot1-I453R, which disrupts Pot1-Tpz1 interaction and
aligns to where hPot1-A532 locates (Figure S5), we suspected
that the hPOT1-A532Pmutationmight reside in the TPP1 (human
counterpart of fission yeast Tpz1) interaction surface. Thus,
hPOT1-A532P might disrupt hPOT1-hTPP1 interaction, thereby
facilitating tumorigenesis by causing inappropriate telomere
elongation, similar to fission yeast Pot1-I453R. To test this
possibility, we in vitro translated hPOT1 and its mutants and
evaluated their binding abilities to GST-hTPP1-NTD. Notably,
hPOT1-A532P, as well as two other mutants in the adjacent re-
gions, hPOT1-V529R and L538R, has significantly weakened
hPOT1-hTPP1 interaction (Figures 6A and 6B). This result em-
phasizes the importance of the intact ‘‘shelterin bridge’’ in telo-
mere length regulation and explains how mutations in a shelterin
component overcome the replicative telomere barrier, and thus
lead to tumorigenesis.
DISCUSSION
MICro-MS Is Effective in Identifying Functional
Protein-Protein Contact Residues
Identifying interfaces between protein components, and gener-
ating separation-of-function mutants thereafter, is a prerequisite
for elucidating the functional role of each component in the large
multi-protein complex, such as the shelterin complex at the end
of our chromosomes. For proteins that have multiple interaction
partners, such as Tpz1 in fission yeast shelterin complex, its
separation-of-function mutants are absolutely required to eluci-
date the specific roles of each of these protein interactions.
However, X-ray crystallography and NMR spectroscopy have
been the main experimental techniques that provide the struc-
tural details of protein-protein interfaces, and consequently,
the knowledge to design separation-of-function mutants. Both
approaches are very time consuming, labor intensive, and ex-
tremely demanding on the chemical and biophysical behavioruthors
of the protein complex. Thus, only a limited number of protein
complexes are suitable for these high-resolution techniques.
Here, utilizing XL-MS with a recently developed MS-cleavable
linker DSSO, coupled with phylogenetic and biochemical ana-
lyses, we present an integrated strategy (Figure 1B) that suc-
cessfully identified contact residues in Tpz1-centered protein-
protein interfaces of fission yeast shelterin. The DSSO-based
XL-MS workflow greatly facilitates the identification of cross-
linked peptides, which, in turn, provides essential information
about regions that are very likely tomediate protein-protein inter-
actions. Phylogenetic analysis further narrows down the candi-
date residues to be mutated in the regions close to crosslinked
residues, and, thereafter, GST pull-down assays identify resi-
dues directly involved in and contribute to the protein-protein
interaction. This strategy can be directly applied to other protein
complexes due to its simplicity, sensitivity, efficiency, accuracy,
and speed. In addition, recent studies suggested the existence
of evolutionarily co-varied residues as good candidates for con-
tact residues across protein interaction interface because
compensatory mutations occur in the interfaces to maintain
interaction stability during evolution (Marks et al., 2011; Ovchin-
nikov et al., 2014; Weigt et al., 2009). Therefore, evolutionary
covariation analysis can be combined with MICro-MS to more
accurately identify interface residues by prioritizing candidate
residues to mutate.
For MICro-MS, chemical crosslinking sets up the foundation
for the overall outcome of this strategy. The linker length of the
chemical crosslinker is crucial for linking residues pairs around
the protein-interaction interface. DSSO has a linker length of
10.1 A˚, resulting in potential linkages between lysines within
20 A˚. This is a distance that has been determined to be optimal
for specifically crosslinking lysines across interfaces. When ly-
sines are scarce in one of the interacting proteins or both, other
crosslinking reagents targeting other amino acid residues such
as cysteines or acidic residues (Leitner et al., 2014) can be uti-
lized similarly to determine protein interaction contacts. Inter-
faces that are small can be potentially probed by crosslinkers
with shorter linker length such as EDC (1-ethyl-3-(3-dimethyla-
minopropyl)carbodiimide hydrochloride), which targets acidic
residues (D and E), with zero linker length. Incorporating CID-
inducible cleavage group into chemical crosslinkers with
different linker lengths and/or reactive groups targeting various
side chains apparently has urgent need.
For structurally heterogeneous samples, crosslinking mass
spectrometry has the advantage of probing proximal regions of
interacting proteins in different conformations. Unlike most other
biophysical techniques, in which sample heterogeneity interferes
with the generation of characteristic signals, for MICro-MS,
different protein interactions existing in different conformations
can be identified as distinct crosslinking pairs with crosslinked
peptide counts proportional to its population in the sample.
Moreover, capturing stable interactions in general is much easier
than identifying transient ones, but stability is not a requirement;
this is another aspect of MICro-MS that allows the stabilization of
transient complexes through chemical crosslinking for subse-
quent analysis to identify residues close to the interfaces. Finally,
methods such as yeast two-hybrid and peptide arrays are known
to identify binary interactions and have been used extensively toCell Repidentify domains that mediate protein interaction. They can
also be utilized to identifying protein-protein interacting sur-
faces residues when coupled with alanine scanning of the whole
or selected region of the protein pairs. In addition, once protein
domains responsible for interaction are identified via yeast
two hybrid, they can be subject to MICro-MS, which provides
leading candidate residues for both methods to test, sig-
nificantly reducing the number of residues to mutate. It is worth
mentioning that MICro-MS allows the study of each individual
interface in multi-protein complexes concurrently.
Shelterin Connectivity, Telomere Length Regulation,
and Familial Melanoma
Our recent study of fission yeast shelterin revealed that the com-
plete linkage within shelterin, connecting double-stranded and
single-stranded telomeric DNA, governs the telomerase-nonex-
tendible state of the telomere (Jun et al., 2013). In this study,
taking advantage of XL-MS with a MS-cleavable linker strategy,
we achieved complete dissection of Tpz1-centered shelterin
component interactions (Tpz1-Ccq1, Tpz1-Poz1, Tpz1-Pot1)
and obtained separation-of-function mutants that facilitate the
investigation of their roles in telomerase regulation, telomere
protection, and potentially other cellular functions such as telo-
mere silencing (Tadeo et al., 2013) and meiosis. These mutants
emphasize the importance of shelterin connectivity in negatively
regulating telomerase as we concluded from Tpz1 separation-
of-function mutants. This is because any mutation that disrupts
the shelterin connectivity from dsDNA to ssDNA, no matter in
Tpz1 or in the Tpz1 interacting partners, uniformly leads to
over-elongated telomeres. They also make exploring the regula-
tion of telomere length homeostasis by shelterin components,
especially its activator Ccq1 (Webb and Zakian, 2012), possible.
In addition, our study also has clinical significance. Since
fission yeast and human have homologous shelterin compo-
nents and architecture, the shelterin interaction interface infor-
mation obtained from fission yeast can be easily applied to the
human shelterin. This information will not only help design sepa-
ration-of-functionmutants of human shelterin components, it will
also offer mechanistic insights to a constellation of genetic dis-
eases caused by impaired telomere maintenance due to defects
in telomere shelterin. Human POT1 is the first member of shel-
terin components whose loss-of-function variants were found
to predispose to human cancers, such as familial melanoma (Ro-
bles-Espinoza et al., 2014; Shi et al., 2014) and chronic lympho-
cytic (Ramsay et al., 2013; Speedy et al., 2014). Many identified
POT1 mutations occurs in the N-terminal OB-fold domain that
directly binds to the telomeric ssDNA. All four well-studied OB-
fold domain mutants of hPOT1 identified in familial melanoma
patients, e.g., POT1-Y89C, POT1-Q94E, POT1-R273L, and
POT1-S270N, fail to bind to telomeric ssDNA and cause cells
to have elongated telomeres (Robles-Espinoza et al., 2014; Shi
et al., 2014). This can be mechanistically explained by the loss
of complete linkage connecting telomeric dsDNA to ssDNA via
shelterin, due to the inability of the mutants to bind to ssDNA,
and thereby keeping the telomere constitutively in the extendible
state. With sufficiently long telomeres reserve, tumorigenesis
will not be impeded by the lack of telomerase in the cell, and can-
cer cells thus can automatically overcome the anti-proliferativeorts 12, 2169–2180, September 29, 2015 ª2015 The Authors 2177
Figure 7. Model of Telomere Length Dysregulation-Related
Tumorigenesis
Upregulation of positive regulators of telomere elongation (such as hTERT)
is equivalent to downregulation of the negative regulators (such as the
shelterin bridge) in leading to the deregulated telomere over-elongation, both
helping the cancer cells to achieve replicative immortality, a key barrier to
tumorigenesis.barrier set by short telomeres (Taboski et al., 2012). Long telo-
meres help cells gain replicative time in order to accumulate
other mutations (loss of function for tumor suppressor and gain
of function for tumor activator). Exploiting homology between
fission yeast and human shelterins, we find that another POT1
mutation (POT1-A532P), found in familial melanoma patients, af-
fects POT1-TPP1 interaction. Based on what we learned from
fission yeast, disrupting any point in the proteinaceous shelterin
bridge between telomeric dsDNA and ssDNAwould lead to elon-
gated telomeres. Therefore, in that sense, defect in POT1-TPP1
interaction is equivalent to that in POT1-ssDNA interaction, both
acting to downregulate the negative force of telomere elonga-
tion. Recently, in addition to POT1, point mutations clustered
in the POT1-interacting domain of TPP1were found inmelanoma
patients (Aoude et al., 2015), presumably disrupting POT1-
TPP1 interaction just as POT1-A532P does. Interestingly, gain-
of-function mutations in the hTERT promoter, which increase
gene expression of hTERT, were recently found to be driver alter-
ations in melanoma and other cancers (Horn et al., 2013; Huang
et al., 2013). Upregulation of positive regulators of telomere elon-
gation (such as hTERT) is equivalent to downregulation of the
negative regulators (such as the shelterin bridge) (as shown in
Figure 7) in leading to the deregulated telomere over-elongation,
both helping the cancer cells to achieve replicative immortality,
during and after the transformation.EXPERIMENTAL PROCEDURES
Yeast Strains, Gene Tagging, and Mutagenesis
Fission yeast strains used in this study are listed in Table S1. Single mutant
strains were constructed by one-step gene replacement of the entire open
reading frame (ORF) with the selectable marker. Double- and triple-mutant
strains were produced by mating, sporulation, dissection, and selection fol-
lowed by PCR verification of genotypes. Genes were fused to specific epitope
tags at the C terminus by homologous recombination; the pFA6a plasmid
modules were used as templates for PCR (Ba¨hler et al., 1998; Sato et al.,2178 Cell Reports 12, 2169–2180, September 29, 2015 ª2015 The A2005). Point mutations were made by site-directed mutagenesis PCR using
the high-fidelity polymerase Pfu (Agilent). All mutations were confirmed by
DNA sequencing (Eton).
Protein Expression and Purification
Plasmids for recombinant protein expression in E. coli were transformed into
Rosetta-BL21 (DE3) cells. Protein expression was induced with 0.4 mM iso-
propyl-b-D-1-thiogalactopyranoside (IPTG) for 4 hr at 30C or 0.2 mM IPTG
overnight at 16C. Cells were disrupted by sonication in lysis buffer (25 mM
Tris-HCl [pH 8.0], 350 mM NaCl, 15 mM imidazole, 5 mM b-mercaptoethanol,
1 mM PMSF, 2 mM benzamidine). The supernatant was incubated with Ni-
NTA (QIAGEN) resin for 1 hr. After washing, the bound protein was eluted
from the beads with elution buffer containing 300 mM imidazole. Some pro-
teins were further purified with additional ion-exchange and/or gel filtration
steps.
GST Pull-Down Assay
15 mg GST fusion protein in 30 ml GST pull-down buffer (50 mM Tris-HCl [pH
8.0], 200 mM NaCl, 10 mM b-ME, 0.1% Tween 20) was incubated with 20 ml
glutathione Sepharose resin (QIAGEN) for 1 hr. Then the target protein
(20 mg in 120 ml GST pull-down buffer) was added to the resin. After 1-hr incu-
bation with rotation, the resin was washed three times, and the protein was
eluted with 15 ml 23 SDS loading buffer at 95C for 5 min. The eluted proteins
were resolved by 10% SDS-PAGE and visualized by Coomassie blue staining.
Crosslinking Mass Spectrometry Analysis
45 ml purified protein complex (4.5 mg/ml for Tpz1-Ccq1; 4 mg/ml for Tpz1-
Poz1; 1.25 mg/ml for Tpz1-Pot1) was mixed with 5 ml DSSO (dissolved in
DMSO) to the final concentration as indicated in results. Crosslinking was per-
formed for 30 min and quenched with 2 ml 1 M Tris-HCl (pH 8.0) for 15 min. The
cysteine residues were reduced with 4 mM TCEP and alkylated with 20 mM
iodoacetamide in dark, followed by terminating alkylation reaction with
20 mM cysteine for 30 min. The crosslinked proteins were digested overnight
at 37C with trypsin (2%, w/w) and chymotrypsin (5%, w/w), separately.
Crosslinked peptides were analyzed by LC MSn utilizing an LTQ-Orbitrap XL
MS (Thermo Fisher Scientific) coupled online with an Easy-nLC 1000 (Thermo
Fisher Scientific) as described (Kao et al., 2011). Each MSn experiment con-
sists of one MS scan in FT mode (350–1,400 m/z, resolution of 60,000 at m/
z 400) followed by two data-dependent MS2 scans in FT mode (resolution of
7,500) with normalized collision energy at 20% on the top two MS peaks
with charges 3+ or up, and three MS3 scans in the LTQ with normalized colli-
sion energy at 35% on the top three peaks from each MS2.
Identification of DSSO Crosslinked Peptides by LC-MSn
MS3 data were subjected to a developmental version of Protein Prospector
(v.5.10.10) for database searching, using Batch-Tag with mass tolerances
for parent ions and fragment ions set as ±20 ppm and 0.6 Da, respectively.
Trypsin was set as the enzyme with five maximum missed cleavages allowed.
A maximum of five variable modifications were also allowed, including protein
N-terminal acetylation, methionine oxidation, N-terminal conversion of gluta-
mine to pyroglutamic acid, asparagine deamidation, and cysteine carbamido-
methylation. In addition, three defined modifications on uncleaved lysines and
free protein N termini were also selected: alkene (A: C3H2O, +54 Da); sulfenic
acid (S: C3H4O2S, +104 Da), and unsaturated thiol (T: C3H2OS, +86 Da) mod-
ifications, due to remnant moieties of DSSO. Initial acceptance criteria for pep-
tide identification required a reported expectation value%0.1.
Integration of MSn data was carried out using the in-house program Link-
Hunter, a revised version of the previously written Link-Finder program, to vali-
date and summarize crosslinked peptides as previously described (Kao et al.,
2011, 2012).
Co-immunoprecipitation
The indicated strains were grown in YEAU and harvested at OD600 = 0.6–0.8.
Then the cell pellets were cryogenically disrupted with FastPrep MP with two
pulses (60 s) of bead-beating in ice-cold lysis buffer (50 mM HEPES [pH 7.5],
140 mM NaCl, 15 mM EGTA, 15 mM MgCl2, 0.1% NP40, 0.5 mM Na3VO4,
1 mM NaF, 2 mM PMSF, 2 mM benzamidine, Complete proteinase inhibitoruthors
[Roche]). The crude extracts were clarified by centrifuge for 10 min and
adjusted to 15 mg/ml. Anti-Flag M2 affinity gel (Sigma) or anti-Myc resin
(9E10, Santa Cruz Biotechnology) was equilibrated with same lysis buffer,
and immunoprecipitation was performed for 3 hr at 4C. Then, the proteins
were eluted with 30 ml 0.1 M glycine (pH 2.0) at room temperature for 10 min
with gentle shaking and neutralized by Tris-HCl (pH 8.0) immediately after
elution. Eluted proteins were resolved by 8% SDS-PAGE and then subjected
to western blotting. Western blot analysis was performed using monoclonal
anti-Flag (M2-F1804, from Sigma), monoclonal anti-Myc (9E10, from Cova-
nce), monoclonal anti-HA (F-7, from Santa Cruz), anti-Ccq1 rabbit serum,
and anti-Cdc2 (y100.4, from Abcam). 20 mg whole-cell extract was used for
input control.
Telomere Length Analysis
S. pombe cells grown in 5 ml YEAU overnight were harvest for genomic DNA
extraction. EcoRI-digested genomic DNA was separated on 1% agarose gel
and then transferred to N+ membrane (GE Healthcare) via capillary blot. The
telomeric probe was prepared as previously described (Jun et al., 2013). The
template of pol1+ was amplified with 50 primer (GGTGCAGAAGACGGTCTG
CAAG) and 30 primer (CTTAGCATGCAGAAGCATGCGC), and the pol1+ probe
was generated by High Prime (Roche). Southern blots were imaged using a
Bio-Rad phosphorimager.
In Vitro Translation Coupled with GST Pull-Down Assay
hPOT1 in a pET28 vector was mutated by site-directed mutagenesis PCR. WT
and all mutants were in vitro expressed using TnT coupled reticulocyte lysate
kit (Promega) following the manual. Briefly, a 25-ml reaction containing 20 ml
rabbit reticulocyte lysate, 0.5 mg plasmid, 1 ml 1mM methionine, and 1 ml
[35S]methionine was incubated at 30C for 90 min. 22 ml of each in vitro trans-
lation reaction was directly applied to GST pull-down assay as previously
described, but with 7 mg of GST fusion protein. The pull-downs were resolved
by 8% SDS-PAGE and imaged with a Bio-Rad phosphorimager.
Electrophoretic Mobility Shift Assay
20 nM 50 end 32P-labeled ssDNA (GTTACGGTTACAGGTTACG) was mixed
with Pot1 proteins of specified concentrations in 20 ml reaction buffer
(20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 5 mM DTT, 2 mM MgCl2, 10% glyc-
erol). The mixtures were then incubated at 4C for 30 min. The protein-ssDNA
complex were resolved by 7% non-denaturing polyacrylamide gel and imaged
with a Bio-Rad phosphorimager.
Chromatin Immunoprecipitation
Fresh S. pombe cells in liquid culture were fixed with an 11% formaldehyde
solution (11% formaldehyde, 100 mM NaCl, 1 mM EDTA [pH 8.0], 0.5 mM
EGTA, 50 mM Tris-HCl [pH 8.0]) for 20 min, followed by termination with
125 mM glycine for 5 min. Cell pellets were disrupted in 400 ml of lysis buffer
(50 mM HEPES [pH 7.5], 140 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.1% sodium deoxycholate, complete proteinase inhibitor [Roche], 1 mM
PMSF, 1 mM benzamidine, 1 mM Na3VO4, 1 mM NaF) with FastPrep MP.
After three pulses (1 min) of beads-beating, at least 90% cells were broken.
Cell extracts were sonicated three times for 30 s in 18 cycles using a Bio-
ruptor. Clarified cell extracts were incubated with anti-Myc resin (9E10,
Santa Cruz) or anti-Ccq1 rabbit serum followed by protein G-agarose
(Roche) for 3 hr at 4C. Then, the beads were washed twice with lysis
buffer, lysis buffer with 500 mM NaCl, wash buffer, and 1 3 TE buffer
sequentially. Each sample was added with 100 ml of 10% Chelex100 resin
and boiled for 15 min, followed by 20 mg proteinase K treatment for 30 min
at 55C. The recovered DNA were denatured with 0.4 M NaOH and trans-
ferred to a Hybond-XL membrane by using a slot module. The blots were
hybridized with telomeric probe; the same blot was then re-probed with
rDNA probe after stripping.
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